| |
| |
|
| Insider
Information: |
Bansal Ajay |
| Relationship: |
See Remarks |
| City: |
San Carlos |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
147,888 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$40,118 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
147,888 |
|
|
| Total
Value |
$40,118 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nektar Therapeutics |
NKTR |
Former CFO |
2006-03-10 |
5,166 |
2004-03-01 |
0 |
Premium* |
|
|
Onconova Therapeutics, Inc. |
ONTX |
Chief Financial Officer |
2013-07-30 |
43,846 |
|
0 |
Premium* |
|
|
Viewray, Inc. |
VRAY |
Chief Financial Officer |
2019-07-25 |
98,876 |
2016-12-15 |
0 |
Premium* |
|
|
Urovant Sciences Ltd. |
UROV |
See Remarks |
2021-03-29 |
0 |
2019-11-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| UROV |
Urovant Sciences Ltd. |
See Remarks |
• – – |
2021-03-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(140,098) |
0 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
PFO;CFO/Urovant Sciences, Inc. |
• – – |
2020-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
63,659 |
138,659 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
PFO;CFO/Urovant Sciences, Inc. |
• – – |
2019-11-05 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
75,000 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
Chief Financial Officer |
• – – |
2019-07-25 |
4 |
D |
$9.00 |
$39,672 |
D/D |
(4,408) |
98,876 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
Chief Financial Officer |
• – – |
2019-07-25 |
4 |
OE |
$3.17 |
$39,685 |
D/D |
12,519 |
103,284 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
Chief Financial Officer |
• – – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,661 |
90,765 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
Chief Financial Officer |
• – – |
2017-01-18 |
4 |
B |
$3.17 |
$198,432 |
D/D |
62,597 |
70,104 |
2.74 |
- |
|
| VRAY |
Viewray, Inc. |
Chief Financial Officer |
• – – |
2016-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
7,507 |
7,507 |
0 |
- |
|
| ONTX |
Onconova Therapeutics, In... |
Chief Financial Officer |
• – – |
2013-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
23,785 |
43,846 |
0 |
- |
|
| ONTX |
Onconova Therapeutics, In... |
Chief Financial OfficerOfficer |
• – – |
2013-07-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,061 |
|
- |
|
| NKTR |
Nektar Therapeutics |
Former CFO |
– – – |
2006-03-10 |
4 |
AS |
$19.85 |
$102,932 |
D/D |
(5,167) |
5,166 |
|
- |
|
| NKTR |
Nektar Therapeutics |
Former CFO |
– – – |
2006-03-08 |
4 |
A |
$0.01 |
$83 |
D/D |
8,333 |
10,333 |
|
- |
|
| NKTR |
Nektar Therapeutics |
Former CFO |
– – – |
2006-03-03 |
4 |
A |
$0.01 |
$20 |
D/D |
2,000 |
2,000 |
|
- |
|
| NKTR |
Nektar Therapeutics |
CFO, VP Finance & Admin |
• – – |
2005-09-07 |
4 |
AS |
$19.96 |
$59,880 |
D/D |
(3,000) |
0 |
|
- |
|
| NKTR |
Nektar Therapeutics |
CFO, VP Finance & Admin |
• – – |
2005-09-07 |
4 |
OE |
$5.43 |
$16,287 |
D/D |
3,000 |
0 |
|
- |
|
| NKTR |
Nektar Therapeutics |
CFO, VP Finance & Admin |
• – – |
2005-05-17 |
4 |
S |
$16.41 |
$68,384 |
D/D |
(4,166) |
0 |
|
- |
|
| NKTR |
Nektar Therapeutics |
CFO, VP Finance & Admin |
• – – |
2005-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
4,166 |
4,166 |
|
- |
|
| NKTR |
Nektar Therapeutics |
CFO, VP Finance & Admin |
• – – |
2005-01-03 |
4 |
OE |
$5.43 |
$38,003 |
D/D |
7,000 |
25,000 |
|
- |
|
| NKTR |
Nektar Therapeutics |
CFO, VP Finance & Admin |
• – – |
2005-01-03 |
4 |
AS |
$20.06 |
$140,420 |
D/D |
(7,000) |
25,000 |
|
- |
|
| NKTR |
Nektar Therapeutics |
CFO, VP Finance & Admin |
• – – |
2004-12-01 |
4 |
AS |
$20.00 |
$30,000 |
D/D |
(1,500) |
25,000 |
|
- |
|
| NKTR |
Nektar Therapeutics |
CFO, VP Finance & Admin |
• – – |
2004-12-01 |
4 |
OE |
$5.43 |
$8,144 |
D/D |
1,500 |
25,000 |
|
- |
|
| NKTR |
Nektar Therapeutics |
CFO, VP Finance & Admin |
• – – |
2004-03-04 |
4 |
AS |
$21.80 |
$65,740 |
D/D |
(3,000) |
25,000 |
|
- |
|
| NKTR |
Nektar Therapeutics |
CFO, VP Finance & Admin |
• – – |
2004-03-04 |
4 |
OE |
$5.06 |
$15,188 |
D/D |
3,000 |
25,000 |
|
- |
|
| NKTR |
Nektar Therapeutics |
CFO, VP Finance & Admin |
• – – |
2004-03-01 |
4 |
A |
$0.01 |
$250 |
D/D |
25,000 |
25,000 |
|
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
